Study: Cutaneous leishmaniasis responds to simple wound care

05/14/2013 | Healio

Cutaneous leishmaniasis may be best treated with local therapy and simple wound care instead of potentially toxic systemic treatments, according to a study published in Clinical Infectious Diseases. The researchers found that 92% of patients treated with simple wound care had positive outcomes after 42 and 60 days, compared with 79% of patients treated with cryotherapy and intralesional antimony injections, and 60% of patients who received systemic therapy.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA